Expensive drugs to be cut from cancer drugs fund
NHS England is to start evaluating the cost effectiveness of medicines available through the cancer drugs fund in a bid to bring the budget under control
You need to be an HSJ subscriber to read more
Subscribe to read the full article
With an HSJ subscription you’ll get access to:
- Expert Briefing newsletters, covering nine topics and regions
- Weekly Catch Up – a summary of the week’s most important stories
- Unlimited access to hsj.co.uk
- The HSJ app
Enquire about multi-user access